MedTrace Logo

Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome

NCT03794908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-10-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effect a morning light treatment has on improving physical function, pain intensity, and pain sensitivity in people with fibromyalgia syndrome (FMS).

Conditions

  • Fibromyalgia
  • FMS

Interventions

DEVICE

Light therapy A (Bright) via the Re-Timer®

Subjects will conduct light treatment in the mornings at home for one hour using Re-timer®.

DEVICE

Light therapy B (Dim) via the Re-Timer®

Subjects will conduct light treatment in the mornings at home for one hour using Re-timer®.

Sponsors & Collaborators

Principal Investigators

  • Helen Burgess · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2021-07-15
Completion
2021-07-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03794908 on ClinicalTrials.gov